Molina Healthcare, Inc. (NYSE:MOH) Shares Sold by Wealthfront Advisers LLC

Wealthfront Advisers LLC reduced its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 35.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,885 shares of the company's stock after selling 3,162 shares during the quarter. Wealthfront Advisers LLC's holdings in Molina Healthcare were worth $1,713,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. True Wealth Design LLC grew its position in Molina Healthcare by 2,500.0% in the 3rd quarter. True Wealth Design LLC now owns 104 shares of the company's stock valued at $36,000 after acquiring an additional 100 shares in the last quarter. Versant Capital Management Inc grew its position in shares of Molina Healthcare by 83.1% during the fourth quarter. Versant Capital Management Inc now owns 163 shares of the company's stock worth $47,000 after buying an additional 74 shares in the last quarter. Wingate Wealth Advisors Inc. acquired a new position in shares of Molina Healthcare during the fourth quarter worth about $52,000. Financial Perspectives Inc acquired a new position in shares of Molina Healthcare during the fourth quarter worth about $59,000. Finally, Lindbrook Capital LLC grew its position in shares of Molina Healthcare by 38.5% during the fourth quarter. Lindbrook Capital LLC now owns 205 shares of the company's stock worth $60,000 after buying an additional 57 shares in the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Molina Healthcare

In other news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the sale, the director now owns 17,375 shares in the company, valued at $5,235,608.75. This represents a 5.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.10% of the company's stock.

Remove Ads

Molina Healthcare Stock Performance

NYSE MOH traded down $2.41 on Wednesday, reaching $314.66. The stock had a trading volume of 543,722 shares, compared to its average volume of 606,946. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. Molina Healthcare, Inc. has a 12-month low of $262.32 and a 12-month high of $423.92. The business's 50-day moving average price is $298.86 and its 200 day moving average price is $309.90. The stock has a market cap of $17.46 billion, a P/E ratio of 15.40, a price-to-earnings-growth ratio of 1.06 and a beta of 0.56.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing analysts' consensus estimates of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. As a group, equities analysts expect that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on MOH shares. JPMorgan Chase & Co. reissued a "neutral" rating and set a $350.00 price objective (down from $378.00) on shares of Molina Healthcare in a research report on Tuesday, December 17th. Stephens reissued an "equal weight" rating and set a $345.00 price objective on shares of Molina Healthcare in a research report on Thursday, February 6th. Truist Financial lowered their price objective on Molina Healthcare from $370.00 to $340.00 and set a "buy" rating for the company in a research report on Wednesday, February 19th. Barclays decreased their target price on Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating for the company in a research note on Friday, February 7th. Finally, UBS Group decreased their target price on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research note on Friday, February 7th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $355.69.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.